Knobil Katharine 4
4 · PLIANT THERAPEUTICS, INC. · Filed Sep 16, 2022
Insider Transaction Report
Form 4
Knobil Katharine
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-14+30,000→ 30,000 totalExercise: $24.23Exp: 2032-09-13→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of September 14, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date.